IMC001 for Clinical Research on Advanced Digestive System Malignancies
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
A Phase I Clinical Study of Autologous T cells modified with chimeric antigen receptor
targeting EpCAM ( EPCAM CAR-T) in Patients with malignant tumors of the digestive system
(including advanced gastric cancer, colorectal cancer, liver cancer and pancreatic cancer) .